Talimogene Laherparepvec in Combination with Immunotherapy, A Viable Option? Zager JS, van Akkooi ACJ. Ann Surg Oncol 2023;30:1279-1281.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zager JS, van Akkooi ACJ. Talimogene Laherparepvec in Combination with Immunotherapy, A Viable Option? Ann Surg Oncol 2023;30:1279-1281.
PMID: 36520235